{
    "2018-11-04": [
        [
            {
                "time": "",
                "original_text": "云南白药重大重组存蹊跷 被指侵害中小股东利益",
                "features": {
                    "keywords": [
                        "云南白药",
                        "重大重组",
                        "中小股东",
                        "权益侵害"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}